Mechanisms of Network Changes in Cognitive Impairment in Multiple Sclerosis
Danka Jandric1, Ilona Lipp1, David Paling1
1From the Division of Neuroscience & Experimental Psychology (D.J., H.H., L.P., G.P., N.M.), School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, UK; Department of Neurophysics (I.L.), Max Planck Institute for Human Cognitive & Brain Sciences, Leipzig, Germany; Royal Hallamshire Hospital (D.P.), Sheffield Teaching Hospitals, NHS UK; Salford Royal Hospital (D.R.), Salford Royal NHS Foundation Trust, NHS UK; NMR Research Unit (G.C.), Queens Square Multiple Sclerosis Centre, and Centre for Medical Image Computing (G.C., G.P.), Department of Computer Science and Department of Neuroinflammation, Queen Square Institute of Neurology, University College London; Cardiff University Brain Research Imaging Centre (V.T.), Cardiff University, UK; Institute for Advanced Biomedical Technologies (ITAB) (V.T.), Department of Neurosciences, Imaging and Clinical Sciences, University G. d'Annunzio of Chieti-Pescara; and Multiple Sclerosis Centre (V.T.), Department of Neurology, SS Annunziata University Hospital, Chieti, Italy.
Background And Objectives:
Cognitive impairment in multiple sclerosis (MS) is associated with functional connectivity abnormalities. While there have been calls to use functional connectivity measures as biomarkers, there remains to be a full understanding of why they are affected in MS. In this cross-sectional study, we tested the hypothesis that functional network regions may be susceptible to disease-related "wear and tear" and that this can be observable on co-occurring abnormalities on other magnetic resonance metrics. We tested whether functional connectivity abnormalities in cognitively impaired patients with MS co-occur with (1) overlapping, (2) local, or (3) distal changes in anatomic connectivity and cerebral blood flow abnormalities.
Methods:
Multimodal 3T MRI and assessment with the Brief Repeatable Battery of Neuropsychological tests were performed in 102 patients with relapsing-remitting MS and 27 healthy controls. Patients with MS were classified as cognitively impaired if they scored ≥1.5 SDs below the control mean on ≥2 tests (n = 55) or as cognitively preserved (n = 47). Functional connectivity was assessed with Independent Component Analysis and dual regression of resting-state fMRI images. Cerebral blood flow maps were estimated, and anatomic connectivity was assessed with anatomic connectivity mapping and fractional anisotropy of diffusion-weighted MRI. Changes in cerebral blood flow and anatomic connectivity were assessed within resting-state networks that showed functional connectivity abnormalities in cognitively impaired patients with MS.
Results:
Functional connectivity was significantly decreased in the anterior and posterior default mode networks and significantly increased in the right and left frontoparietal networks in cognitively impaired relative to cognitively preserved patients with MS (threshold-free cluster enhancement corrected at p ≤ 0.05, 2 sided). Networks showing functional abnormalities showed altered cerebral blood flow and anatomic connectivity locally and distally but not in overlapping locations.
Discussion:
We provide the first evidence that functional connectivity abnormalities are accompanied by local cerebral blood flow and structural connectivity abnormalities but also demonstrate that these effects do not occur in exactly the same location. Our findings suggest a possibly shared pathologic mechanism for altered functional connectivity in brain networks in MS.
Related Concept Videos
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Cognitive Development During Adulthood
Long-term Depression
Calcium Ion Concentration Mechanism
If over...
Neuroplasticity
Role of Neurotransmitters in Memory
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...


